Fresenius Medical Care Sees US Plans for Kidney Disease as Positive
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
A group of more than 650 nephrologists have joined with FMCNA to form InterWell Health.
This group of more than 650 nephrologists along with FMCNA have raised $20 million in initial funding.
The primary goal of InterWell Health is to support and encourage all nephrology practices and other renal providers across the country to participate in value based arrangements. InterWell Health will facilitate and support renal providers across the country to create value in managing the chronic kidney disease and end stage renal disease patient population by improving patient outcomes and lowering overall costs to the system.
Over the past several years, InterWell Health investors have participated in various value based arrangements, including the End Stage Renal Disease Seamless Care Organization (ESCO) program.
InterWell Health is uniquely positioned to expand its high-performing network of renal providers to collaborate with both public and private payors under value based arrangements. The joint venture partnership will foster collaboration among clinicians across the country to support their value based operations. The combined clinical and analytical expertise of the nephrology practices and FMCNA will be leveraged to provide shared know-how, state-of-the-art models of care, and other resources for value based arrangements in local and national markets.
Please use the ‘contact us’ form below to request additional information.